Effects of cumin on nonalcoholic steatohepatitis: A double blind, randomised, controlled trial.

Autor:	Shavakhi A; Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Torki M; Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Khodadoostan M; Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Shavakhi S; Medical Students' Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran.
Jazyk:	angličtina
Zdroj:	Advanced biomedical research [Adv Biomed Res] 2015 Sep 28; Vol. 4, pp. 212. Date of Electronic Publication: 2015 Sep 28 (Print Publication: 2015).
DOI:	10.4103/2277-9175.166149
Abstrakt:	Background: This study was designed to evaluate the effect of cumin on nonalcoholic steatohepatitis (NASH) in compare to placebo. Materials and Methods: One hundred patients with histopathological diagnosis NASH in two groups of case and control received oral cumin capsule or placebo thrice daily for 6 months. Clinical and laboratory data were body mass index (BMI), serum triglyceride, serum total cholesterol, alanine aminotransferase (ALT), aspartate aminotransferase (AST), high-density lipoprotein (HDL), low-density lipoprotein (LDL), fasting blood sugar (FBS), steatosis grade, and side-effects and were measured at baseline and after treatment period using standard clinical chemistry techniques. The grade of steatosis was assessed by liver sonography in 3 stages (mild, moderate and severe). Results: Of 100 eligible patients during follow-up 10/50 cases and 9/50 controls were excluded. At baseline and after treatment BMI, triglyceride, cholesterol, ALT, AST, HDL, LDL, and FBS were not statistically significant between groups (P ≥ 0.5). BMI, triglyceride, cholesterol, ALT, AST, LDL, and FBS after treatment decreased compare to baseline but were not statistically significant (P ≥ 0.5). The mean of changes in the level of BMI, triglyceride, cholesterol, ALT, LDL and FBS were not statistically significant (P ≥ 0.5). The mean of changes in AST and HDL between groups was significant (P < 0.05). The grade of steatosis before and after treatment between studied groups was not statistically significant (P ≥ 0.5). Side-effects were not statistically significant among the two groups. Conclusion: Findings show that there the effect of cumin in in the treatment of NASH was not significantly different in compare to placebo.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu